High-fat diet-induced neuropathy of prediabetes and obesity: Effect of PMI-5011, an ethanolic extract of artemisia dracunculus L.

Mediators of Inflammation

Volumn 2010, Issue , 2010, Pages

  Obrosova, Irina G ^a   Watcho, Pierre ^a   Stavniichuk, Roman ^a   Ribnicky, David M ^b   Raskin, Ilya ^b  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE; ARTEMISIA DRACUNCULUS EXTRACT; PLANT EXTRACT; PMI 5011; UNCLASSIFIED DRUG; PMI-5011;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTEMISIA; ARTEMISIA DRACUNCULUS; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; ENZYME INDUCTION; FAT INTAKE; HYPERGLYCEMIA; HYPOALGESIA; IMPAIRED GLUCOSE TOLERANCE; MALE; MOUSE; NERVE CONDUCTION DISORDER; NERVOUS SYSTEM INFLAMMATION; NEUROPATHY; NITROSATIVE STRESS; NONHUMAN; OBESITY; OXIDATIVE STRESS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSORY NEUROPATHY; TREATMENT DURATION; ANIMAL; ANIMAL BEHAVIOR; C57BL MOUSE; CHEMISTRY; DIABETIC NEUROPATHY; GLUCOSE BLOOD LEVEL; HUMAN; METABOLISM; PAIN ASSESSMENT; PATHOLOGY; PHYSIOLOGY;

ARTEMISIA; ARTEMISIA DRACUNCULUS; MUS;

ANIMALS; ARTEMISIA; BEHAVIOR, ANIMAL; BLOOD GLUCOSE; DIABETIC NEUROPATHIES; DIETARY FATS; HUMANS; MALE; MICE; MICE, INBRED C57BL; OBESITY; PAIN MEASUREMENT; PLANT EXTRACTS; PREDIABETIC STATE;

EID: 77952501888     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2010/268547     Document Type: Article

References (57)

1. Boulton A. J. M., Vinik A. I., Arezzo J. C., Diabetic neuropathies: a statement by the American Diabetes Association Diabetes Care 2005 28 4 956 962
2. Sumner C. J., Sheth S., Griffin J. W., Cornblath D. R., Polydefkis M., The spectrum of neuropathy in diabetes and impaired glucose tolerance Neurology 2003 60 1 108 111
3. Pittenger G. L., Mehrabyan A., Simmons K., Small fiber neuropathy is associated with the metabolic syndrome Metabolic Syndrome and Related Disorders 2005 3 2 113 121
4. Singleton J. R., Smith A. G., Neuropathy associated with prediabetes: what is new in 2007? Current Diabetes Reports 2007 7 420 424
5. Oltman C. L., Coppey L. J., Gellett J. S., Davidson E. P., Lund D. D., Yorek M. A., Progression of vascular and neural dysfunction in sciatic nerves of Zucker diabetic fatty and Zucker rats American Journal of Physiology 2005 289 1 E113 E122
6. Obrosova I. G., Ilnytska O., Lyzogubov V. V., High-fat diet-induced neuropathy of pre-diabetes and obesity: effects of healthy diet and aldose reductase inhibition Diabetes 2007 56 10 2598 2608
7. Vincent A. M., Hayes J. M., McLean L. L., Vivekanandan-Giri A., Pennathur S., Feldman E. L., Dyslipidemia-induced neuropathy in mice: the role of oxLDL/LOX-1 Diabetes 2009 58 10 2376 2385
8. Veves A., Backonja M., Malik R. A., Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options Pain Medicine 2008 9 6 660 674
9. Obrosova I. G., Diabetic Painful and Insensate Neuropathy: pathogenesis and Potential Treatments Neurotherapeutics 2009 6 4 638 647
10. Tan R. X., Zheng W. F., Tang H. Q., Biologically active substances from the genus Artemisia Planta Medica 1998 64 4 295 302
11. Watson L. E., Bates P. L., Evans T. M., Unwin M. M., Estes J. R., Molecular phylogeny of Subtribe Artemisiinae (Asteraceae), including Artemisia and its allied and segregate genera BMC Evolutionary Biology 2002 26 2 17
12. Al-Waili N. S. D., Treatment of diabetes mellitus by Artemisia herba-alba extract: preliminary study Clinical and Experimental Pharmacology and Physiology 1986 13 7 569 573
13. Subramoniam A., Pushpangadan P., Rajasekharan S., Evans D. A., Latha P. G., Valsaraj R., Effects of Artemisia pallens Wall. on blood glucose levels in normal and alloxan-induced diabetic rats Journal of Ethnopharmacology 1996 50 1 13 17
14. Hong J. H., Lee I. S., Effects of Artemisia capillaris ethyl acetate fraction on oxidative stress and antioxidant enzyme in high-fat diet induced obese mice Chemico-Biological Interactions 2009 179 2-3 88 93
15. Mio J., Moscatelli V., Hnatyszyn O., Gorzalczany S., Acevedo C., Ferraro G., Antinociceptive and antiinflammatory activities of Artemisia copa extracts Pharmacological Research 2004 50 1 59 63
16. Ribnicky D. M., Poulev A., ONeal J., Toxicological evaluation of the ethanolic extract of Artemisia dracunculus L. for use as a dietary supplement and in functional foods Food and Chemical Toxicology 2004 42 4 585 598
17. Ribnicky D. M., Poulev A., Watford M., Cefalu W. T., Raskin I., Antihyperglycemic activity of Tarralin, an ethanolic extract of Artemisia dracunculus L. Phytomedicine 2006 13 8 550 557
18. Logendra S., Ribnicky D. M., Yang H., Bioassay-guided isolation of aldose reductase inhibitors from Artemisia dracunculus Phytochemistry 2006 67 14 1539 1546
19. Cameron N. E., Cotter M. A., Basso M., Hohman T. C., Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats Diabetologia 1997 40 3 271 281
20. Nakamura J., Kato K., Hamada Y., A protein kinase C--selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats Diabetes 1999 48 10 2090 2095
21. Yagihashi S., Yamagishi S.-I., Wada R.-I., Neuropathy in diabetic mice overexpressing human aldose reductase and effects of aldose reductase inhibitor Brain 2001 124 12 2448 2458
22. Obrosova I. G., Van Huysen C., Fathallah L., Cao X. C., Greene D. A., Stevens M. J., An aldose reductase inhibitor reverses early diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense The FASEB Journal 2002 16 1 123 125
23. Ho E. C. M., Lam K. S. L., Yuk S. C., Aldose reductase-deficient mice are protected from delayed motor nerve conduction velocity, increased c-Jun NH2-terminal kinase activation, depletion of reduced glutathione, increased superoxide accumulation, and DNA damage Diabetes 2006 55 7 1946 1953
24. Obrosova I. G., Li F., Abatan O. I., Role of Poly(ADP-Ribose) polymerase activation in diabetic neuropathy Diabetes 2004 53 3 711 720
25. Natarajan R., Nadler J. L., Lipoxygenases and lipid signaling in vascular cells in diabetes Frontiers in Bioscience 2003 8 supplement s783 s795
26. Natarajan R., Nadler J. L., Lipid inflammatory mediators in diabetic vascular disease Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 9 1542 1548
27. Low P. A., Nickander K. K., Tritschler H. J., The roles of oxidative stress and antioxidant. Treatment in experimental diabetic neuropathy Diabetes 1997 46 supplement 2 S38 S42
28. Cameron N. E., Tuck Z., McCabe L., Cotter M. A., Effects of the hydroxyl radical scavenger, dimethylthiourea, on peripheral nerve tissue perfusion, conduction velocity and nociception in experimental diabetes Diabetologia 2001 44 9 1161 1169
29. Shibata T., Naruse K., Kamiya H., Transplantation of bone marrow-derived mesenchymal stem cells improves diabetic polyneuropathy in rats Diabetes 2008 57 11 3099 3107
30. Greene D. A., Arezzo J. C., Brown M. B., Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy Neurology 1999 53 3 580 591
31. Hotta N., Toyota T., Matsuoka K., Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: a 52-week multicenter placebo-controlled double-blind parallel group study Diabetes Care 2001 24 10 1776 1782
32. Ametov A. S., Barinov A., Dyck P. J., The sensory symptoms of diabetic polyneuropathy are improved with-lipoic acid: the Sydney trial Diabetes Care 2003 26 3 770 776
33. Sima A. A. F., Calvani M., Mehra M., Amato A., Acetyl-L-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy: an analysis of two randomized placebo-controlled trials Diabetes Care 2005 28 1 89 94
34. Vinik A. I., Bril V., Kempler P., Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial Clinical Therapeutics 2005 27 8 1164 1180
35. Bril V., Buchanan R. A., Long-term effects of ranirestat (AS-3201) on peripheral nerve function in patients with diabetic sensorimotor polyneuropathy Diabetes Care 2006 29 1 68 72
36. Cameron N. E., Eaton S. E. M., Cotter M. A., Tesfaye S., Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy Diabetologia 2001 44 11 1973 1988
37. Obrosova I. G., Diabetes and the peripheral nerve Biochimica et Biophysica Acta 2009 1792 10 931 940
38. Oates P. J., Aldose reductase, still a compelling target for diabetic neuropathy Current Drug Targets 2008 9 1 14 36
39. Casellini C. M., Barlow P. M., Rice A. L., A 6-month, randomized, double-masked, placebo-controlled study evaluating the effects of the protein kinase C-inhibitor ruboxistaurin on skin microvascular blood flow and other measures of diabetic peripheral neuropathy Diabetes Care 2007 30 4 896 902
40. Grover J. K., Rathi S. S., Vats V., Amelioration of experimental diabetic neuropathy and gastropathy in rats following oral administration of plant (Eugenia jambolana, Mucurna pruriens and Tinospora cordifolia) extracts Indian Journal of Experimental Biology 2002 40 3 273 276
41. Zareba G., Phytotherapy for pain relief Drugs of Today 2009 45 6 445 467
42. Ford I., Cotter M. A., Cameron N. E., Greaves M., The effects of treatment with-lipoic acid or evening primrose oil on vascular hemostatic and lipid risk factors, blood flow, and peripheral nerve conduction in the streptozotocin-diabetic rat Metabolism 2001 50 8 868 875
43. Cameron N. E., Jack A. M., Cotter M. A., Effect of-lipoic acid on vascular responses and nociception in diabetic rats Free Radical Biology and Medicine 2001 31 1 125 135
44. Obrosova I. G., Mabley J. G., Zsengellr Z., Role for nitrosative stress in diabetic neuropathy: evidence from studies with a peroxynitrite decomposition catalyst FASEB Journal 2005 19 3 401 403
45. Drel V. R., Pacher P., Vareniuk I., Evaluation of the peroxynitrite decomposition catalyst Fe(III) tetra-mesitylporphyrin octasulfonate on peripheral neuropathy in a mouse model of type 1 diabetes International Journal of Molecular Medicine 2007 20 6 783 792
46. Obrosova I. G., Drel V. R., Oltman C. L., Role of nitrosative stress in early neuropathy and vascular dysfunction in streptozotocin-diabetic rats American Journal of Physiology 2007 293 6 E1645 E1655
47. Purves T., Middlemas A., Agthong S., A role for mitogen-activated protein kinases in the etiology of diabetic neuropathy FASEB Journal 2001 15 13 2508 2514
48. Price S. A., Agthong S., Middlemas A. B., Tomlinson D. R., Mitogen-activated protein kinase p38 mediates reduced nerve conduction in experimental diabetic neuropathy: interactions with aldose reductase Diabetes 2004 53 7 1851 1856
49. LeRoith D., Fonseca V., Vinik A., Metabolic memory in diabetesfocus on insulin Diabetes/Metabolism Research and Reviews 2005 21 2 85 90
50. Wang Y., Schmeichel A. M., Iida H., Schmelzer J. D., Low P. A., Enhanced inflammatory response via activation of NF-κB in acute experimental diabetic neuropathy subjected to ischemia-reperfusion injury Journal of the Neurological Sciences 2006 247 1 47 52
51. Yamagishi S.-I., Ogasawara S., Mizukami H., Correction of protein kinase C activity and macrophage migration in peripheral nerve by pioglitazone, peroxisome proliferator activated--ligand, in insulin-deficient diabetic rats Journal of Neurochemistry 2008 104 2 491 499
52. Cameron N. E., Cotter M. A., Pro-inflammatory mechanisms in diabetic neuropathy: focus on the nuclear factor kappa B pathway Current Drug Targets 2008 9 1 60 67
53. Doupis J., Lyons T. E., Wu S., Gnardellis C., Dinh T., Veves A., Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neuropathy Journal of Clinical Endocrinology and Metabolism 2009 94 6 2157 2163
54. Nunemaker C. S., Chen M., Pei H., 12-Lipoxygenase-knockout mice are resistant to inflammatory effects of obesity induced by western diet American Journal of Physiology 2008 295 5 E1065 E1075
55. Obrosova I. G., Increased sorbitol pathway activity generates oxidative stress in tissue sites for diabetic complications Antioxidants and Redox Signaling 2005 7 11-12 1543 1552
56. Obrosova I. G., Pacher P., Szab C., Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications Diabetes 2005 54 1 234 242
57. Drel V. R., Pacher P., Stevens M. J., Obrosova I. G., Aldose reductase inhibition counteracts nitrosative stress and poly(ADP-ribose) polymerase activation in diabetic rat kidney and high-glucose-exposed human mesangial cells Free Radical Biology and Medicine 2006 40 8 1454 1465